Attenuated antibody responses to respiratory syncytial virus vaccination in hematologic malignancies: impact of anti-CD20 therapy.

Haematologica · 2026 · PMC13231093 · PMID 41504235

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP =0.08so close (0.05 < p ≤ 0.1)

Seroconversion was numerically higher in MM (12/29, 41.4%) than in CLL (8/33, 24.2%) or B-NHL (2/17, 11.8%), though the difference did not reach statistical significance ( P =0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.